Company Description
Catalent is the global leader in enabling pharmaceutical, biotechnology, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients globally.
With broad scale and deep expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Each year, Catalent helps accelerate over 1,500 partner programs, launches more than 150 new products, and supplies around 80 billion doses of nearly 8,000 products. Catalent’s global network comprises over 50 sites and an expert workforce of approximately 19,000, including over 3,000 scientists and technicians.
Company Background
Founded in 2007, Catalent’s legacy of drug development goes back to 1933 with the formation of R.P. Scherer’s softgel encapsulation process. Headquartered in Somerset, New Jersey, the company is NYSE listed and included in the S&P 500 Index, generating nearly $5 billion in revenue in its 2022 fiscal year.
Facilities
Catalent has a global network of over 55 facilities comprising approximately 8 million square feet of manufacturing, laboratory, and office space. These provide flexible commercial and clinical manufacturing and integrated solutions to transform challenging molecules and new modalities into real treatments.
Services & Capabilities
Catalent applies rigorous science, superior technologies, and deep expertise to improve its partners’ treatments and bring them through the clinic to patients, faster.
Catalent offers integrated development and product supply solutions that can be tailored to enable customers to progress drugs, biologics, and consumer health products. Post-launch, Catalent provides comprehensive, integrated product supply, from sourcing bulk APIs through to manufacturing and packaging, release testing and
distribution. These flexible, scalable, and creative solutions meet the unique needs of partners of all sizes, from the smallest innovators to the largest pharmaceutical and consumer health companies, advancing thousands of molecules to market.
Services include:
• Contract Pharmaceutical Preformulation Services
• Pharmaceutical Preformulation Polymorph Screening
• Pharmaceutical Vial Filling Services
• Sterile Syringe Filling Services Powder Filling Services
• Contract Pharmaceutical Formulation Development Services
• Pharmaceutical Preformulation Solid State Testing Services
• Pharmaceutical Preformulation Salt Screening Services
• Pharmaceutical Preformulation Co-Crystal Selection Services
• Pharmaceutical Dissolution Testing Services
• Pharmaceutical Stability Testing Services
• Pharmaceutical Solubility Testing Services
• Analytical Method Development Services
• Analytical Method Validation Services
• Liquid Dosage Drug Formulation Development Services
• Semi-Solid Dosage Drug Formulation Development Services
• Solid Dosage Drug Formulation Development Services
• Pre-clinical Toxicology Testing Services
• Pharmaceutical
• Microbiology Testing Services
• Pharmaceutical ADME Testing Services
• DMPK Services
• Clinical Trial Supply Chain Management Services
• Outsourcing Clinical Trial Distribution Services
• Cold Chain Management Solutions
• Cell Line Services
• Pharmaceutical Capsule Packaging / Tablet Packaging Services
• Solid Dose Forms Contract Manufacturing Services
• Liquid and Semi-Solid Dosage Form Contract Manufacturing Services